$7.00
0.14%
Nasdaq, Jan 02, 10:00 pm CET

Neogen Corporation Stock price

$7.00
+1.08 18.24% 1M
+1.77 33.84% 6M
+0.01 0.14% YTD
-4.94 41.37% 1Y
-8.23 54.04% 3Y
-32.21 82.15% 5Y
-13.49 65.84% 10Y
+4.67 200.00% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
+0.01 0.14%

Key metrics

Basic
Market capitalization
$1.5b
Enterprise Value
$2.2b
Net debt
$653.7m
Cash
$138.9m
Shares outstanding
217.3m
Valuation (TTM | estimate)
P/E
negative | 28.6
P/S
1.7 | 1.8
EV/Sales
2.5 | 2.6
EV/FCF
negative
P/B
0.7
Financial Health
Equity Ratio
60.1%
Return on Equity
-52.7%
ROCE
-0.6%
ROIC
-0.6%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$886.9m | $839.8m
EBITDA
$49.9m | $164.9m
EBIT
$-20.0m | $-7.1m
Net Income
$-1.0b | $53.2m
Free Cash Flow
$-3.2m
Growth (TTM | estimate)
Revenue
-2.8% | -6.1%
EBITDA
-23.7% | 40.0%
EBIT
-147.9% | -321.4%
Net Income
-4,333.1% | 104.9%
Free Cash Flow
97.5%
Margin (TTM | estimate)
Gross
46.4%
EBITDA
5.6% | 19.6%
EBIT
-2.3%
Net
-117.6% | 6.3%
Free Cash Flow
-0.4%
More
EPS
$-4.8
FCF per Share
$0.0
Short interest
12.5%
Employees
3k
Rev per Employee
$310.0k
Show more

Is Neogen Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Neogen Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Neogen Corporation forecast:

6x Buy
55%
5x Hold
45%

Analyst Opinions

11 Analysts have issued a Neogen Corporation forecast:

Buy
55%
Hold
45%

Financial data from Neogen Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '25
+/-
%
887 887
3% 3%
100%
- Direct Costs 475 475
3% 3%
54%
411 411
9% 9%
46%
- Selling and Administrative Expenses 341 341
7% 7%
38%
- Research and Development Expense 21 21
0% 0%
2%
50 50
24% 24%
6%
- Depreciation and Amortization 70 70
196% 196%
8%
EBIT (Operating Income) EBIT -20 -20
148% 148%
-2%
Net Profit -1,043 -1,043
4,333% 4,333%
-118%

In millions USD.

Don't miss a Thing! We will send you all news about Neogen Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Neogen Corporation Stock News

Neutral
Business Wire
16 days ago
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its second-quarter earnings release before the opening of the market on January 8, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results. The conference call can be accessed by dialing: Toll-Free - North Amer...
Neutral
Business Wire
17 days ago
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in two upcoming investor conferences. The Company will participate in the CJS Securities 26th Annual New Ideas for the New Year conference, held virtually on January 14, 2026. The Company will also participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco...
Neutral
PRNewsWire
18 days ago
SAN DIEGO , Dec. 16, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in Neogen Corporation (NASDAQ: NEOG) shares. Investors who purchased shares of Neogen Corporation prior to January 2023 and continue to hold any of those NASDAQ: NEOG shares also have certain options and contact the Shareholders Foundation at mail@shareholdersfoundat...
More Neogen Corporation News

Company Profile

Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety, Animal Safety, and Corporate and Eliminations. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The Corporate and eliminations segment refers to the corporate assets, including cash and cash equivalents, marketable securities, current and deferred tax accounts, and overhead expenses not allocated to specific business segments. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

Head office United States
CEO John Adent
Employees 2,917
Founded 1981
Website www.neogen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today